BIA
Biondo Investment Advisors Portfolio holdings
AUM
$759M
This Quarter Return
+10.38%
1 Year Return
+16.64%
3 Year Return
+102.11%
5 Year Return
+165.96%
10 Year Return
+637.5%
AUM
$302M
AUM Growth
+$302M
(+2.3%)
Cap. Flow
-$7.22M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
81
New
4
Increased
36
Reduced
26
Closed
6
Top Buys
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$5.04M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$3.24M |
| 3 |
Lowe's Companies
LOW
|
$3.02M |
| 4 |
iShares MSCI New Zealand ETF
ENZL
|
$2.11M |
| 5 |
Meta Platforms (Facebook)
META
|
$562K |
Top Sells
| 1 |
Ford
F
|
$4.02M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$3.8M |
| 3 |
JPM.WS
JPMorgan Chase
JPM.WS
|
$2.81M |
| 4 |
iShares MSCI Belgium ETF
EWK
|
$2.47M |
| 5 |
Under Armour
UAA
|
$1.85M |
Sector Composition
| 1 | Healthcare | 26.04% |
| 2 | Financials | 13.65% |
| 3 | Energy | 11.95% |
| 4 | Communication Services | 10.49% |
| 5 | Technology | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$538B
| $22.9M | 7.56% | 221,329 -3,970 | -2% | -$410K |
|
2
Intuitive Surgical
ISRG
$170B
| $18.9M | 6.24% | 29,730 -2,766 | -9% | -$1.75M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $16.5M | 5.44% | 142,202 -840 | -0.6% | -$97.2K |
|
|
BAC.WS.A
4
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $15.6M | 5.15% | 1,563,855 -7,100 | -0.5% | -$70.6K |
|
5
Apple
AAPL
$3.45T
| $15.4M | 5.1% | 133,251 -1,897 | -1% | -$220K |
|
|
JPM.WS
6
DELISTED
JPMorgan Chase
JPM.WS
| $13.8M | 4.57% | 312,002 -63,385 | -17% | -$2.81M |
|
|
7
Meta Platforms (Facebook)
META
$1.86T
| $12.6M | 4.18% | 109,835 +4,885 | +5% | +$562K |
|
8
JPMorgan Chase
JPM
$829B
| $11M | 3.64% | 127,413 -3,580 | -3% | -$309K |
|
9
Idexx Laboratories
IDXX
$51.8B
| $9.59M | 3.17% | 81,746 +1,125 | +1% | +$132K |
|
|
10
Alphabet (Google) Class A
GOOGL
$2.57T
| $9.05M | 2.99% | 11,418 +4,085 | +56% | +$3.24M |
|
11
Schlumberger
SLB
$55B
| $8.19M | 2.71% | 97,574 +775 | +0.8% | +$65.1K |
|
12
Diamondback Energy
FANG
$43.1B
| $7.46M | 2.47% | 73,802 +980 | +1% | +$99K |
|
13
Bristol-Myers Squibb
BMY
$96B
| $6.24M | 2.06% | 106,828 -19,092 | -15% | -$1.12M |
|
14
Chevron
CVX
$324B
| $5.73M | 1.89% | 48,647 +155 | +0.3% | +$18.2K |
|
15
Core Laboratories
CLB
$540M
| $5.33M | 1.76% | 44,427 -90 | -0.2% | -$10.8K |
|
|
EGRX
16
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.04M | 1.67% | +63,575 | New | +$5.04M |
|
17
Illumina
ILMN
$15.8B
| $4.76M | 1.57% | 37,149 -9,404 | -20% | -$1.2M |
|
18
Verizon
VZ
$186B
| $4.67M | 1.54% | 87,468 +9,970 | +13% | +$532K |
|
19
VF Corp
VFC
$5.91B
| $4.6M | 1.52% | 86,278 -1,135 | -1% | -$60.6K |
|
20
Pacira BioSciences
PCRX
$1.2B
| $4.6M | 1.52% | 142,473 -20,600 | -13% | -$665K |
|
21
Regeneron Pharmaceuticals
REGN
$61.5B
| $4.38M | 1.45% | 11,935 +465 | +4% | +$171K |
|
22
Lockheed Martin
LMT
$106B
| $4.36M | 1.44% | 17,448 +200 | +1% | +$50K |
|
23
3M
MMM
$82.8B
| $3.98M | 1.32% | 22,267 +92 | +0.4% | +$16.4K |
|
24
Philip Morris
PM
$260B
| $3.97M | 1.31% | 43,391 +649 | +2% | +$59.4K |
|
25
AbbVie
ABBV
$372B
| $3.77M | 1.25% | 60,172 +687 | +1% | +$43K |
|